293 related articles for article (PubMed ID: 22759657)
1. Domain landscapes of somatic mutations in cancer.
Nehrt NL; Peterson TA; Park D; Kann MG
BMC Genomics; 2012 Jun; 13 Suppl 4(Suppl 4):S9. PubMed ID: 22759657
[TBL] [Abstract][Full Text] [Related]
2. Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing.
Shajani-Yi Z; de Abreu FB; Peterson JD; Tsongalis GJ
Neoplasia; 2018 Mar; 20(3):256-262. PubMed ID: 29454261
[TBL] [Abstract][Full Text] [Related]
3. De novo discovery of mutated driver pathways in cancer.
Vandin F; Upfal E; Raphael BJ
Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
[TBL] [Abstract][Full Text] [Related]
4. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.
Baeissa H; Benstead-Hume G; Richardson CJ; Pearl FMG
Oncotarget; 2017 Mar; 8(13):21290-21304. PubMed ID: 28423505
[TBL] [Abstract][Full Text] [Related]
5. Protein domain-level landscape of cancer-type-specific somatic mutations.
Yang F; Petsalaki E; Rolland T; Hill DE; Vidal M; Roth FP
PLoS Comput Biol; 2015 Mar; 11(3):e1004147. PubMed ID: 25794154
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer.
Palacio-Rúa KA; Isaza-Jiménez LF; Ahumada-Rodríguez E; Muñetón-Peña CM
Rev Gastroenterol Mex; 2014; 79(2):79-89. PubMed ID: 24861525
[TBL] [Abstract][Full Text] [Related]
7. Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Fleck JL; Pavel AB; Cassandras CG
BMC Syst Biol; 2016 Jan; 10():12. PubMed ID: 26810975
[TBL] [Abstract][Full Text] [Related]
8. Identification of cancer driver genes based on nucleotide context.
Dietlein F; Weghorn D; Taylor-Weiner A; Richters A; Reardon B; Liu D; Lander ES; Van Allen EM; Sunyaev SR
Nat Genet; 2020 Feb; 52(2):208-218. PubMed ID: 32015527
[TBL] [Abstract][Full Text] [Related]
9. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
Bokhari Y; Alhareeri A; Arodz T
BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
[TBL] [Abstract][Full Text] [Related]
10. Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples.
Peterson TA; Gauran IIM; Park J; Park D; Kann MG
PLoS Comput Biol; 2017 Apr; 13(4):e1005428. PubMed ID: 28426665
[TBL] [Abstract][Full Text] [Related]
11. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
12. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
Hua X; Xu H; Yang Y; Zhu J; Liu P; Lu Y
Am J Hum Genet; 2013 Sep; 93(3):439-51. PubMed ID: 23954162
[TBL] [Abstract][Full Text] [Related]
13. Cancer Gene Discovery by Network Analysis of Somatic Mutations Using the MUFFINN Server.
Han H; Lehner B; Lee I
Methods Mol Biol; 2019; 1907():37-50. PubMed ID: 30542989
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer assessment of mutational landscape in intrinsically disordered hotspots reveals potential driver genes.
Zou H; Pan T; Gao Y; Chen R; Li S; Guo J; Tian Z; Xu G; Xu J; Ma Y; Li Y
Nucleic Acids Res; 2022 May; 50(9):e49. PubMed ID: 35061901
[TBL] [Abstract][Full Text] [Related]
15. High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer.
Korphaisarn K; Pongpaibul A; Roothumnong E; Pongsuktavorn K; Thamlikitkul L; Anekpuritanang T; Poungvarin N; Thongnoppakhun W; Pithukpakorn M
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2319-2326. PubMed ID: 31450901
[TBL] [Abstract][Full Text] [Related]
16. Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control.
Wang J; Zhang Y; Shen X; Zhu J; Zhang L; Zou J; Guo Z
Mol Biosyst; 2011 Apr; 7(4):1158-66. PubMed ID: 21279201
[TBL] [Abstract][Full Text] [Related]
17. Network-Based Coverage of Mutational Profiles Reveals Cancer Genes.
Hristov BH; Singh M
Cell Syst; 2017 Sep; 5(3):221-229.e4. PubMed ID: 28957656
[TBL] [Abstract][Full Text] [Related]
18. Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.
Tokheim C; Bhattacharya R; Niknafs N; Gygax DM; Kim R; Ryan M; Masica DL; Karchin R
Cancer Res; 2016 Jul; 76(13):3719-31. PubMed ID: 27197156
[TBL] [Abstract][Full Text] [Related]
19. Identification of constrained cancer driver genes based on mutation timing.
Sakoparnig T; Fried P; Beerenwinkel N
PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
[TBL] [Abstract][Full Text] [Related]
20. Identification of rare cancer driver mutations by network reconstruction.
Torkamani A; Schork NJ
Genome Res; 2009 Sep; 19(9):1570-8. PubMed ID: 19574499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]